Exact Mass: 370.2984

Exact Mass Matches: 370.2984

Found 93 metabolites which its exact mass value is equals to given mass value 370.2984, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Docosanedioic acid

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


Phellogenic acid, also known as 1,20-eicosanedicarboxylic acid or 1,22-docosanedioate, is a member of the class of compounds known as very long-chain fatty acids. Very long-chain fatty acids are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, phellogenic acid is considered to be a fatty acid lipid molecule. Phellogenic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Phellogenic acid can be found in potato, which makes phellogenic acid a potential biomarker for the consumption of this food product. Docosanedioic acid is an alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids. It has a role as a metabolite. It is an alpha,omega-dicarboxylic acid and a dicarboxylic fatty acid. It is a conjugate acid of a docosanedioate(2-). It derives from a hydride of a docosane. Docosanedioic acid is a natural product found in Pinus radiata with data available.

   

Diethylhexyl adipate

Hexanedioic acid, 1,6-bis(2-ethylhexyl) ester

C22H42O4 (370.3083)


Diethylhexyl adipate (DEHA) is an indirect food additive arising from contact with polymers and adhesives. DEHA is a plasticizer. DEHA is an ester of 2-ethylhexanol and adipic acid. Its chemical formula is C22H42O4. Indirect food additive arising from contact with polymers and adhesives

   

trans-2-Tetradecenoylcarnitine

(3R)-3-[(2E)-Tetradec-2-enoyloxy]-4-(trimethylazaniumyl)butanoic acid

C21H40NO4 (370.2957)


trans-2-Tetradecenoylcarnitine is an acylcarnitine. More specifically, it is an trans-2-tetradecenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. trans-2-Tetradecenoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine trans-2-tetradecenoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular trans-2-tetradecenoylcarnitine is elevated in the blood or plasma of individuals with very long-chain acyl-CoA dehydrogenase (VLACD) deficiency (PMID: 25843429, PMID: 19327992, PMID: 11433098, PMID: 18670371, PMID: 12828998), trifunctional protein (mitochondrial long-chain ketoacyl-coa thiolase) deficiency (PMID: 16423905), mitochondrial dysfunction in diabetes patients (PMID: 28726959), acadvl acyl-coa dehydrogenase very long chain deficiency (PMID: 29491033), nonalcoholic fatty liver disease (NAFLD) (PMID: 27211699), and insulin resistance type 2 diabetes (PMID: 24358186). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Dioctyl hexanedioate

1,6-dioctyl hexanedioate

C22H42O4 (370.3083)


Dioctyl hexanedioate is a food additive [Goodscents]. Food additive [Goodscents]

   

Myristoleoylcarnitine

(3R)-3-[(9Z)-tetradec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate

C21H40NO4 (370.2957)


Myristoleoylcarnitine is an acylcarnitine. More specifically, it is an myristoleoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Myristoleoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine myristoleoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular myristoleoylcarnitine is elevated in the blood or plasma of individuals with very long-chain acyl-CoA dehydrogenase (VLACD) deficiency (PMID: 25843429, PMID: 19327992, PMID: 11433098, PMID: 18670371, PMID: 12828998), trifunctional protein (mitochondrial long-chain ketoacyl-coa thiolase) deficiency (PMID: 16423905), mitochondrial dysfunction in diabetes patients (PMID: 28726959), acadvl acyl-coa dehydrogenase very long chain deficiency (PMID: 29491033), nonalcoholic fatty liver disease (NAFLD) (PMID: 27211699), and insulin resistance type 2 diabetes (PMID: 24358186).Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). Myristoleoylcarnitine has also been identified in the human placenta (PMID: 32033212 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Acetylconanin|N-Acetyl-conimin

Acetylconanin|N-Acetyl-conimin

C24H38N2O (370.2984)


   

Dimethyl icosanedioate

Dimethyl icosanedioate

C22H42O4 (370.3083)


   

1-O-(2-Hydroxy-4-cis-hexadecenyl)-2,3-isopropylidenglycerol

1-O-(2-Hydroxy-4-cis-hexadecenyl)-2,3-isopropylidenglycerol

C22H42O4 (370.3083)


   

carbomethoxyoctadecanol acetate

carbomethoxyoctadecanol acetate

C22H42O4 (370.3083)


   

plakortide U

plakortide U

C22H42O4 (370.3083)


   

3-Acetoxy-icosanoic acid

3-Acetoxy-icosanoic acid

C22H42O4 (370.3083)


   

Ac-20-Hydroxyeicosanoic acid

Ac-20-Hydroxyeicosanoic acid

C22H42O4 (370.3083)


   

Dioctyl adipate

1,6-dioctyl hexanedioate

C22H42O4 (370.3083)


   

FA 22:1;O2

3-Acetoxy-eicosanoic acid

C22H42O4 (370.3083)


   

WD 22:1;O2

hexanedioic acid,1,6-bis[(2R)-ethylhexyl] ester

C22H42O4 (370.3083)


   

SFAHFA

2-acetoxy-eicosanoic acid

C22H42O4 (370.3083)


   

FAHFA 22:0;O

3-tetradecanoyloxy-octanoic acid

C22H42O4 (370.3083)


   

Hexanedioic acid, di-C7-9-branched and linear alkyl esters

Hexanedioic acid, di-C7-9-branched and linear alkyl esters

C22H42O4 (370.3083)


   

2-octadecylbutanedioic acid

2-octadecylbutanedioic acid

C22H42O4 (370.3083)


   

3-Hexadecyl-1-methyl-1H-iImidazolium nitrate

3-Hexadecyl-1-methyl-1H-iImidazolium nitrate

C20H40N3O3 (370.307)


   

Boc-C16-COOH

Boc-C16-COOH

C22H42O4 (370.3083)


   

DIISOOCTYL ADIPATE

DIISOOCTYL ADIPATE

C22H42O4 (370.3083)


   

PB 28 dihydrochloride

1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine

C24H38N2O (370.2984)


   

2-(2-hydroxyethoxy)ethyl monooleate

2-(2-hydroxyethoxy)ethyl monooleate

C22H42O4 (370.3083)


   

1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)ethane

1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)ethane

C22H44P2 (370.2918)


   

1,3-Dihydroxypropan-2-YL nonadec-9-enoate

1,3-Dihydroxypropan-2-YL nonadec-9-enoate

C22H42O4 (370.3083)


   

Dihexyl sebacate

Dihexyl sebacate

C22H42O4 (370.3083)


   

505-56-6

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


   

[(2R)-3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2R)-3-carboxy-2-[(Z)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-4-enyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-4-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-7-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(3E,5E)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

[(3E,5E)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-9-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2R)-3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2R)-3-carboxy-2-[(E)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(E)-tetradec-5-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(Z)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-11-enyl]-trimethylazanium

[(Z)-2-(carboxymethyl)-2-hydroxy-3-oxohexadec-11-enyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(2S)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

[(2S)-2-(carboxymethyl)-2,16-dihydroxyhexadeca-3,5-dienyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

[(1S)-3-carboxy-1-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

[(1S)-3-carboxy-1-[(E)-tetradec-2-enoyl]oxypropyl]-trimethylazanium

C21H40NO4+ (370.2957)


   

9-Acetyloxyicosanoic acid

9-Acetyloxyicosanoic acid

C22H42O4 (370.3083)


   

9-(Butyryloxy)octadecanoic acid

9-(Butyryloxy)octadecanoic acid

C22H42O4 (370.3083)


   

Fahfa 18:0/4:0

Fahfa 18:0/4:0

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentanoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentanoate

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] butanoate

C22H42O4 (370.3083)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexanoate

C22H42O4 (370.3083)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate

C22H42O4 (370.3083)


   

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] acetate

[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] acetate

C22H42O4 (370.3083)


   

2,3-dihydroxypropyl (Z)-nonadec-9-enoate

2,3-dihydroxypropyl (Z)-nonadec-9-enoate

C22H42O4 (370.3083)


   

Fahfa 15:0/7:0

Fahfa 15:0/7:0

C22H42O4 (370.3083)


   

Fahfa 5:0/17:0

Fahfa 5:0/17:0

C22H42O4 (370.3083)


   

Fahfa 19:0/3:0

Fahfa 19:0/3:0

C22H42O4 (370.3083)


   

Fahfa 17:0/5:0

Fahfa 17:0/5:0

C22H42O4 (370.3083)


   

Fahfa 13:0/9:0

Fahfa 13:0/9:0

C22H42O4 (370.3083)


   

Fahfa 3:0/19:0

Fahfa 3:0/19:0

C22H42O4 (370.3083)


   

Fahfa 9:0/13:0

Fahfa 9:0/13:0

C22H42O4 (370.3083)


   

Fahfa 8:0/14:0

Fahfa 8:0/14:0

C22H42O4 (370.3083)


   

Fahfa 7:0/15:0

Fahfa 7:0/15:0

C22H42O4 (370.3083)


   

Fahfa 14:0/8:0

Fahfa 14:0/8:0

C22H42O4 (370.3083)


   

Fahfa 6:0/16:0

Fahfa 6:0/16:0

C22H42O4 (370.3083)


   

Fahfa 16:0/6:0

Fahfa 16:0/6:0

C22H42O4 (370.3083)


   

Fahfa 12:0/10:0

Fahfa 12:0/10:0

C22H42O4 (370.3083)


   

Fahfa 10:0/12:0

Fahfa 10:0/12:0

C22H42O4 (370.3083)


   

Fahfa 11:0/11:0

Fahfa 11:0/11:0

C22H42O4 (370.3083)


   

2-Icosanoyloxyacetic acid

2-Icosanoyloxyacetic acid

C22H42O4 (370.3083)


   

Docosanedioic_acid

1,20-Eicosanedicarboxylic acid

C22H42O4 (370.3083)


Docosanedioic acid is an alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids. It has a role as a metabolite. It is an alpha,omega-dicarboxylic acid and a dicarboxylic fatty acid. It is a conjugate acid of a docosanedioate(2-). It derives from a hydride of a docosane. Docosanedioic acid is a natural product found in Pinus radiata with data available. An alpha,omega-dicarboxylic acid that is docosane in which the methyl groups have been oxidised to the corresponding carboxylic acids.

   

BIS(2-ETHYLHEXYL) ADIPATE

BIS(2-ETHYLHEXYL) ADIPATE

C22H42O4 (370.3083)


   

DG(19:1)

DG(8:1(1)_11:0)

C22H42O4 (370.3083)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

NA-Tryptamine 14:0

NA-Tryptamine 14:0

C24H38N2O (370.2984)


   

FAHFA 10:0/3O-12:0

FAHFA 10:0/3O-12:0

C22H42O4 (370.3083)


   

FAHFA 10:0/O-12:0

FAHFA 10:0/O-12:0

C22H42O4 (370.3083)


   

FAHFA 11:0/3O-11:0

FAHFA 11:0/3O-11:0

C22H42O4 (370.3083)


   

FAHFA 11:0/O-11:0

FAHFA 11:0/O-11:0

C22H42O4 (370.3083)


   

FAHFA 12:0/3O-10:0

FAHFA 12:0/3O-10:0

C22H42O4 (370.3083)


   

FAHFA 12:0/O-10:0

FAHFA 12:0/O-10:0

C22H42O4 (370.3083)


   

FAHFA 13:0/3O-9:0

FAHFA 13:0/3O-9:0

C22H42O4 (370.3083)


   

FAHFA 13:0/O-9:0

FAHFA 13:0/O-9:0

C22H42O4 (370.3083)


   

FAHFA 14:0/3O-8:0

FAHFA 14:0/3O-8:0

C22H42O4 (370.3083)


   

FAHFA 14:0/O-8:0

FAHFA 14:0/O-8:0

C22H42O4 (370.3083)


   

FAHFA 16:0/3O-6:0

FAHFA 16:0/3O-6:0

C22H42O4 (370.3083)


   

FAHFA 4:0/12O-18:0

FAHFA 4:0/12O-18:0

C22H42O4 (370.3083)


   

FAHFA 6:0/3O-16:0

FAHFA 6:0/3O-16:0

C22H42O4 (370.3083)


   

FAHFA 7:0/15O-15:0

FAHFA 7:0/15O-15:0

C22H42O4 (370.3083)


   

FAHFA 8:0/2O-14:0

FAHFA 8:0/2O-14:0

C22H42O4 (370.3083)


   

FAHFA 8:0/O-14:0

FAHFA 8:0/O-14:0

C22H42O4 (370.3083)


   

FAHFA 9:0/3O-13:0

FAHFA 9:0/3O-13:0

C22H42O4 (370.3083)


   

FAHFA 9:0/O-13:0

FAHFA 9:0/O-13:0

C22H42O4 (370.3083)


   

2,3-dihydroxypropyl (9z)-10-methyloctadec-9-enoate

2,3-dihydroxypropyl (9z)-10-methyloctadec-9-enoate

C22H42O4 (370.3083)


   

1,6-bis[(2s)-2-ethylhexyl] hexanedioate

1,6-bis[(2s)-2-ethylhexyl] hexanedioate

C22H42O4 (370.3083)